Effects of consumption of the test food on the immune function in healthy Japanese subjects
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-UMIN000047899
- Lead Sponsor
- ORTHOMEDICO Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 11
Not provided
1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5. Subjects who currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who are pregnant, lactation, or planning to become pregnant 8. Subjects who suffer from COVID-19 9. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 10. Subjects who are judged as ineligible to participate in the study by the physician 11. Subjects whose working hours are irregular 12. Subjects whose ifestyles are irregular (such as dietary habits, exercise habits, and sleeping habits) 13. Subjects who have autoimmune disease 14. Subjects who are taking immunosuppressants such as steroids 15. Subjects who have perennial allergic rhinitis 16. Subjects who are currently undergoing treatment of insomnia or sleep disorder 17. Subjects who are smokers 18. Subjects who have lactose intolerance 19. Subjects who have a medical history or history of present illness of immunodeficiency, severe bowel disease, valvular heart disease, or hepatic cirrhosis 20. Subjects who are undergoing central venous catheterization
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Scoring of immunological vigor
- Secondary Outcome Measures
Name Time Method